Unreasonable Fellows

Max Rye

Co-founder NeoGlyco Therapeutics

Max is an Unreasonable Fellow. Max has participated in 2 programs, including Unreasonable Impact World Forum 2021.
Passionate, strategic, and dedicated to advancing innovation that addresses humanity's most pressing challenges is my vision. I am firmly committed to drive impactful change in biotech industry by leading the development of cutting-edge solutions that leverage technology to revolutionize healthcare and improve lives.
Now working with a world class team of scientists creating the next generation of antibodies to treat cancer.
previously founded a biotech company and raised over $42 Million